Retatrutide has emerged as a new medication in the fight against obesity. This revolutionary drug, classified as a dual GLP-1 and GIP receptor agonist, demonstrates promising results in investigations. By boosting these receptors, Retatrutide reduces hunger pangs, {promotesenergy expenditure, and ultimately leads to aod-9604 significant slimming.